share_log

康哲藥業:自願性及業務進展公告 磷酸蘆可替尼乳膏在中國獲得AD適應症三期藥物臨床試驗批准通知書

CMS: Voluntary and Business Update Announcement Approval to Conduct a Phase 3 Clinical Trial Investigating Ruxolitinib Cream in Atopic Dermatitis in China

香港交易所 ·  Mar 19 08:17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more